Alice Mims, MD
Hematology · Columbus, OHNPI 1699962084
Payments from drug & device makers
Across 200 payments — averaging $11,423 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Servier Bioinnovation$682K
- AbbVie$390K
- Agios Pharmaceuticals, Inc.$332K
- Aptevo Therapeutics Inc$328K
- Novartis$202K
- Boehringer Ingelheim International GmbH$159K
- plus $191K from 17 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Servier Bioinnovation | 16 | $681,932 |
| AbbVie | 40 | $390,472 |
| Agios Pharmaceuticals, Inc. | 34 | $332,265 |
| Aptevo Therapeutics Inc | 12 | $327,938 |
| Novartis | 4 | $202,148 |
| Boehringer Ingelheim International GmbH | 13 | $158,755 |
| Astellas Pharma Global Development | 9 | $50,385 |
| Janssen Research & Development, LLC | 4 | $42,859 |
| Bayer | 20 | $34,659 |
| Servier Pharmaceuticals LLC | 6 | $26,388 |
| Bristol Myers Squibb | 7 | $14,008 |
| Jazz Pharmaceuticals Inc. | 14 | $9,078 |
| Genentech USA, Inc. | 3 | $5,577 |
| Sanofi US Services Inc. | 1 | $2,823 |
| Daiichi Sankyo Inc. | 1 | $1,875 |
| Syndax Pharmaceuticals, Inc. | 1 | $1,400 |
| E.r. Squibb & Sons, L.L.C. | 2 | $1,038 |
| AstraZeneca | 4 | $451 |
| Taiho Oncology, Inc. | 4 | $257 |
| Rigel Pharmaceuticals, Inc. | 2 | $136 |
| Gilead | 1 | $125 |
| Amgen | 1 | $29 |
| Astellas Pharma US Inc | 1 | $10 |
How this compares
$2,284,607 in reported general payments places this provider in the 80th percentile of 84 hematology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Columbus
- Jennifer WoyachColumbus$406.1M
- Kerry RogersColumbus$39.6M
- Uma BorateColumbus$23.8M
- Kami MaddocksColumbus$14.2M
- Naresh BummaColumbus$4.9M
- Narendranath EpperlaColumbus$3.6M
- Lapo AlinariColumbus$3.1M
- Spero CatalandColumbus$2.8M
- Seema BhatColumbus$2.7M
- Nicole GrieselhuberColumbus$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.